Healthcare company Baxter International (NYSE:BAX) met Wall Street's revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter's revenue ...

Expanded Baxter Growth and Performance System (GPS) as the enterprise operating system for continuous improvement, launching more than 230 initiatives in the first quarter, with additional efforts ...

Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking operational ...

Healthcare company Baxter International (NYSE:BAX) reported Q2 CY2026 results , with sales up 5.3% year on year to $2.96 billion. Its non-GAAP profit of $0.56 per share was 52.5% above analysts’ ...

"We now expect organic sales growth of 2% to 3% for 2026" and "total sales growth to be 3% to 4% on a reported basis" (Interim CFO Zielinski). "Given the tariff refund in the quarter, we are raising ...

The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition ...

In the latest quarter, 7 analysts provided ratings for Baxter Intl (NYSE:BAX), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, ...

Baxter calculates forward-looking non-GAAP financial measures based on forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking organic ...